The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 318.50
Bid: 314.50
Ask: 316.50
Change: 4.00 (1.27%)
Spread: 2.00 (0.636%)
Open: 317.00
High: 318.50
Low: 313.00
Prev. Close: 314.50
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Commended by Carbon Disclosure Project

29 Oct 2012 11:52

RNS Number : 7497P
Morgan Crucible Co PLC
29 October 2012
 



Press Release

The Morgan Crucible Company plc

29 October 2012

 

 

Morgan Crucible commended by Carbon Disclosure Project for carbon performance and climate change disclosure

 

Morgan Crucible has been commended by the Carbon Disclosure Project (CDP), which represents 655 institutional investors with $78 trillion in assets, for its approach to the disclosure of climate change information and for the action it is taking to reduce emissions and mitigate the risks of climate change.

 

The Company is one of just seven companies from the FTSE Index featured in CDP's Carbon Performance Leadership Index (CPLI), which highlights FTSE 350 companies that have demonstrated a strong approach to climate strategy and emissions reduction in their CDP responses. 

 

Morgan Crucible is also one of 35 FTSE 350 companies featured in CDP's Carbon Disclosure Leadership Index (CDLI). This index highlights FTSE 350 companies which have displayed a strong approach to information disclosure regarding climate change. Companies are scored on their climate change disclosure and high scores indicate good internal data management and understanding of climate change related issues affecting their company.

 

Much of Morgan Crucible's production involves the use of high-temperature processes and the Group works to continually reduce energy use and CO2 emissions across its divisions and sites. The Group reports the environmental impact of its energy usage and CO2 emissions relative to revenue, described as energy and CO2 "intensity". During 2011, CO2 intensity was down by 5% compared to 2010, and energy intensity was reduced by 6%. Performance is on track to achieve the Group's target to reduce CO2 emissions intensity due to energy use by 5%.

 

 

Both indices, compiled by PwC on behalf of CDP, provide an evaluation tool for institutional investors, based on analysis of the responses to CDP's 2012 questionnaire.

 

Mark Robertshaw, Chief Executive Officer of Morgan Crucible commented: "As a high-tech global manufacturing company we are delighted to be recognised by CDP as one of the leaders in the FTSE 350 in both carbon-related performance and disclosure. Across Morgan Crucible we are working to minimise our environmental footprint whilst leveraging our advanced materials to help make a positive environmental impact through renewable energies and through our high-temperature insulation and related technologies."

 

Paul Simpson, chief executive officer of CDP, commented:

"Companies that make the Carbon Disclosure Leadership Index have demonstrated strong internal data management practices for the measurement of greenhouse gas emissions and energy use. They are also giving clear consideration to the business issues related to climate change and their exposure to climate-related risks and opportunities. This is vital to realising greater efficiencies, protecting the business from risk and capitalizing on opportunities."

 

The FTSE 350 report including names of companies featured in the Carbon Disclosure Leadership Index can be found at www.cdproject.net.

 

 

About Morgan Crucible

Morgan Crucible is an advanced materials company that provides technically complex, bespoke solutions to its customers, enabling them to address global trends such as energy demand, healthcare and environmental sustainability. It has a world leading position in its target niche markets within sectors that include power generation, petrochemical, medical, aerospace and defence. Morgan Crucible has operations in more than 50 countries, including a significant and fast growing presence in the dynamic growth economies of the world such as China, India and Brazil. Its shares are listed on the London Stock Exchange and it is a member of the FTSE 250 index. Further information is available at www.morgancrucible.com.

 

 

About CDP

The Carbon Disclosure Project (CDP) is an international, not-for-profit organization providing the only global system for companies and cities to measure, disclose, manage and share vital environmental information. CDP harnesses the power of market forces, including 655 institutional investors with assets of US$78 trillion, to collect information from companies on their greenhouse gas emissions and assessment of climate change and water risk and opportunity. CDP now holds the largest collection globally of primary climate change and water data and puts these insights at the heart of strategic business, investment and policy decisions. Please visit www.cdproject.net to find out more.

For further enquiries:

 

Mark Robertshaw Morgan Crucible 01753 837000

Kevin Dangerfield Morgan Crucible 01753 837000

Alison Kay Brunswick 0207 404 5959

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABBBDGSXDBGDC
Date   Source Headline
1st May 20245:38 pmRNSHolding(s) in Company
24th Apr 20247:00 amRNSCapital Markets Update
5th Apr 202412:55 pmRNSAnnual Financial Report
4th Apr 20241:16 pmRNSDirector/PDMR Shareholding
27th Mar 20244:52 pmRNSDirector/PDMR Shareholding
27th Mar 20244:50 pmRNSDirector/PDMR Shareholding
27th Mar 20244:49 pmRNSDirector/PDMR Shareholding
27th Mar 20244:48 pmRNSDirector/PDMR Shareholding
14th Mar 20249:42 amRNSDirector/PDMR Shareholding
14th Mar 20249:41 amRNSDirector/PDMR Shareholding
13th Mar 202412:10 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSMorgan Advanced Materials Full Year 2023 Results
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
19th Dec 20231:56 pmRNSDirector/PDMR Shareholding
18th Dec 20234:25 pmRNSBlock listing Interim Review
22nd Nov 202310:07 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNSQ3 Trading Update
9th Oct 20234:43 pmRNSDirector/PDMR Shareholding
26th Sep 202312:24 pmRNSDirector/PDMR Shareholding
16th Aug 202311:27 amRNSDirector/PDMR Shareholding
7th Aug 20235:24 pmRNSDirector/PDMR Shareholding
4th Aug 20237:00 amRNSHalf-Year Results for Period Ended 30 June 2023
13th Jul 20234:49 pmRNSDirector/PDMR Shareholding
5th Jul 20234:51 pmRNSDirector/PDMR Shareholding
29th Jun 20235:06 pmRNSResult of AGM
29th Jun 20237:00 amRNSH1 Trading Update
22nd Jun 202311:50 amRNSBlock listing Interim Review
31st May 20233:52 pmRNSDirector/PDMR Shareholding
26th May 20233:28 pmRNSNotice of Annual General Meeting 2023
24th May 20233:59 pmRNSDirector/PDMR Shareholding
11th May 202312:06 pmRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
11th May 202311:59 amRNSDirector/PDMR Shareholding
9th May 20235:59 pmRNSDirector/PDMR Shareholding
4th May 20235:28 pmRNSAnnual Report & Accounts 2022
3rd May 20235:38 pmRNSDirector/PDMR Shareholding
3rd May 20235:28 pmRNSDirector/PDMR Shareholding
28th Apr 20235:45 pmRNSInformation required by DTR 4.1
28th Apr 20237:00 amRNSFull-year results for the period ended 31 Dec 2022
13th Apr 20237:00 amRNSNotification of Full-Year Results
7th Feb 20237:00 amRNSUpdate on Trading and Cyber Security Incident
18th Jan 20237:00 amRNSAppointment of Chair Designate
10th Jan 20237:00 amRNSNotice of Cyber Security Incident
22nd Dec 202211:01 amRNSBlock listing Interim Review
16th Dec 20224:44 pmRNSHolding(s) in Company
6th Dec 20227:00 amRNSAccelerated Pension Contribution
6th Dec 20227:00 amRNSCapital Markets Event
23rd Nov 202210:01 amRNSDirector/PDMR Shareholding
15th Nov 20225:06 pmRNSDirector/PDMR Shareholding
10th Nov 20228:03 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.